Nicola Winstone

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8⁺T-Cell Epitopes

Nilu Goonetilleke, S. S. Moore, Len Dally et al. · Journal of Virology · 2006 · 236 citations · Full text

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans

Matilu Mwau, Inese Cebere, Julian Sutton et al. · Journal of General Virology · 2004 · 210 citations

Mva.hiva Vaccines, Immunology, Cd4 T Cell Responses +16

Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen

Nicola Winstone, Aaron Wilson, Gavin Morrow et al. · Journal of Virology · 2011 · 65 citations

Viral Immunity, Immunology, Dna Priming Phase +17

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

Ana Guimarães‐Walker, N Mackie, Sean McCormack et al. · Vaccine · 2008 · 56 citations

Clinical Immunology, Medicine, Human Retrovirus +10

Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy

Tom Ford, Claire Wenden, Alison Mbekeani et al. · Vaccine · 2017 · 56 citations · Full text